Dr. Watt is an investment associate at Ascension Ventures, an investment firm specializing in healthcare technology. She previously co-founded and served as CSO of Pro-Arc Diagnostics, a personalized medicine company operating in St. Louis.
Key Highlights
Watt discusses her career journey and insights into venture capital investing in neuroscience and neurotech companies. She explains her role as a VC, which involves making profitable investments, underwriting risk, and structuring deals. Dana highlights key attributes of venture-backable companies, such as exceptional teams, large addressable markets, defensibility, and differentiation. She also discusses challenges and biases in neuroscience investing, including the complexity of brain science, hardware difficulties, long clinical timelines, and subtle readouts.
About Foresight Institute
Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.
Allison Duettmann
The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".
Get Involved with Foresight:
Follow Us: Twitter | Facebook | LinkedIn
Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.
Hosted on Acast. See acast.com/privacy for more information.
